 | • レポートコード：QYR2104Z2587 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、神経膠腫診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（診断（CT、MRI）、治療（手術、化学療法））、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・神経膠腫診断・治療の市場動向 ・企業の競争状況、市場シェア ・神経膠腫診断・治療の種類別市場規模（診断（CT、MRI）、治療（手術、化学療法）） ・神経膠腫診断・治療の用途別市場規模（病院、クリニック） ・神経膠腫診断・治療の北米市場規模2016-2027（アメリカ、カナダ） ・神経膠腫診断・治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・神経膠腫診断・治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・神経膠腫診断・治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・神経膠腫診断・治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Thermo Fisher Scientific、Emcure Pharmaceuticals、Sigma-Aldrich、Pfizer、Taj Pharmaceuticals、Novartis International、Teva Pharmaceutical、GE Healthcare、Siemens Healthcare、Philips Healthcare、Shimadzu Corporation、Canon Medical Systems、Merck、Roche、Arbor Pharmaceuticals、Sun Pharmaceutical） ・結論 |
A glioma is a type of tumor that originates in the brain and is also known as a primary brain tumor. There are numerous types of gliomas which are entitled based on the origin of the cell type including oligodendrogliomas, astrocytoma, ependymomas, and glioblastoma. Nearly 33 percent of all brain tumors are gliomas.
Astrocytoma is the most common types of glioma diagnosed worldwide, as more than 30% of all the diagnosed cases with brain tumors are astrocytoma. These types of tumors are not curable as they spread easily through normal brain tissue. The American Brain Tumor Association has evaluated that around 7% of all the primary brain tumors represent astrocytoma.
Market Analysis and Insights: Global Glioma Diagnosis and Treatment Market
The global Glioma Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Glioma Diagnosis and Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Glioma Diagnosis and Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Glioma Diagnosis and Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Glioma Diagnosis and Treatment market.
Global Glioma Diagnosis and Treatment Scope and Market Size
Glioma Diagnosis and Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Glioma Diagnosis and Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Diagnosis (CT, MRI)
Treatment (Surgery, Chemotherapy)
Segment by Application
Hospitals
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Thermo Fisher Scientific
Emcure Pharmaceuticals
Sigma-Aldrich
Pfizer
Taj Pharmaceuticals
Novartis International
Teva Pharmaceutical
GE Healthcare
Siemens Healthcare
Pfizer
Taj Pharmaceuticals
Canon Medical Systems
Merck
Roche
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glioma Diagnosis and Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diagnosis (CT, MRI)
1.2.3 Treatment (Surgery, Chemotherapy)
1.3 Market by Application
1.3.1 Global Glioma Diagnosis and Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Glioma Diagnosis and Treatment Market Perspective (2016-2027)
2.2 Glioma Diagnosis and Treatment Growth Trends by Regions
2.2.1 Glioma Diagnosis and Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Glioma Diagnosis and Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Glioma Diagnosis and Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Glioma Diagnosis and Treatment Industry Dynamic
2.3.1 Glioma Diagnosis and Treatment Market Trends
2.3.2 Glioma Diagnosis and Treatment Market Drivers
2.3.3 Glioma Diagnosis and Treatment Market Challenges
2.3.4 Glioma Diagnosis and Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Glioma Diagnosis and Treatment Players by Revenue
3.1.1 Global Top Glioma Diagnosis and Treatment Players by Revenue (2016-2021)
3.1.2 Global Glioma Diagnosis and Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Glioma Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Glioma Diagnosis and Treatment Revenue
3.4 Global Glioma Diagnosis and Treatment Market Concentration Ratio
3.4.1 Global Glioma Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glioma Diagnosis and Treatment Revenue in 2020
3.5 Glioma Diagnosis and Treatment Key Players Head office and Area Served
3.6 Key Players Glioma Diagnosis and Treatment Product Solution and Service
3.7 Date of Enter into Glioma Diagnosis and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Glioma Diagnosis and Treatment Breakdown Data by Type
4.1 Global Glioma Diagnosis and Treatment Historic Market Size by Type (2016-2021)
4.2 Global Glioma Diagnosis and Treatment Forecasted Market Size by Type (2022-2027)
5 Glioma Diagnosis and Treatment Breakdown Data by Application
5.1 Global Glioma Diagnosis and Treatment Historic Market Size by Application (2016-2021)
5.2 Global Glioma Diagnosis and Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Glioma Diagnosis and Treatment Market Size (2016-2027)
6.2 North America Glioma Diagnosis and Treatment Market Size by Type
6.2.1 North America Glioma Diagnosis and Treatment Market Size by Type (2016-2021)
6.2.2 North America Glioma Diagnosis and Treatment Market Size by Type (2022-2027)
6.2.3 North America Glioma Diagnosis and Treatment Market Size by Type (2016-2027)
6.3 North America Glioma Diagnosis and Treatment Market Size by Application
6.3.1 North America Glioma Diagnosis and Treatment Market Size by Application (2016-2021)
6.3.2 North America Glioma Diagnosis and Treatment Market Size by Application (2022-2027)
6.3.3 North America Glioma Diagnosis and Treatment Market Size by Application (2016-2027)
6.4 North America Glioma Diagnosis and Treatment Market Size by Country
6.4.1 North America Glioma Diagnosis and Treatment Market Size by Country (2016-2021)
6.4.2 North America Glioma Diagnosis and Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Glioma Diagnosis and Treatment Market Size (2016-2027)
7.2 Europe Glioma Diagnosis and Treatment Market Size by Type
7.2.1 Europe Glioma Diagnosis and Treatment Market Size by Type (2016-2021)
7.2.2 Europe Glioma Diagnosis and Treatment Market Size by Type (2022-2027)
7.2.3 Europe Glioma Diagnosis and Treatment Market Size by Type (2016-2027)
7.3 Europe Glioma Diagnosis and Treatment Market Size by Application
7.3.1 Europe Glioma Diagnosis and Treatment Market Size by Application (2016-2021)
7.3.2 Europe Glioma Diagnosis and Treatment Market Size by Application (2022-2027)
7.3.3 Europe Glioma Diagnosis and Treatment Market Size by Application (2016-2027)
7.4 Europe Glioma Diagnosis and Treatment Market Size by Country
7.4.1 Europe Glioma Diagnosis and Treatment Market Size by Country (2016-2021)
7.4.2 Europe Glioma Diagnosis and Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Glioma Diagnosis and Treatment Market Size (2016-2027)
8.2 Asia-Pacific Glioma Diagnosis and Treatment Market Size by Type
8.2.1 Asia-Pacific Glioma Diagnosis and Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Glioma Diagnosis and Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Glioma Diagnosis and Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Glioma Diagnosis and Treatment Market Size by Application
8.3.1 Asia-Pacific Glioma Diagnosis and Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Glioma Diagnosis and Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Glioma Diagnosis and Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Glioma Diagnosis and Treatment Market Size by Region
8.4.1 Asia-Pacific Glioma Diagnosis and Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Glioma Diagnosis and Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Glioma Diagnosis and Treatment Market Size (2016-2027)
9.2 Latin America Glioma Diagnosis and Treatment Market Size by Type
9.2.1 Latin America Glioma Diagnosis and Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Glioma Diagnosis and Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Glioma Diagnosis and Treatment Market Size by Type (2016-2027)
9.3 Latin America Glioma Diagnosis and Treatment Market Size by Application
9.3.1 Latin America Glioma Diagnosis and Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Glioma Diagnosis and Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Glioma Diagnosis and Treatment Market Size by Application (2016-2027)
9.4 Latin America Glioma Diagnosis and Treatment Market Size by Country
9.4.1 Latin America Glioma Diagnosis and Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Glioma Diagnosis and Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Glioma Diagnosis and Treatment Market Size (2016-2027)
10.2 Middle East & Africa Glioma Diagnosis and Treatment Market Size by Type
10.2.1 Middle East & Africa Glioma Diagnosis and Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Glioma Diagnosis and Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Glioma Diagnosis and Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Glioma Diagnosis and Treatment Market Size by Application
10.3.1 Middle East & Africa Glioma Diagnosis and Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Glioma Diagnosis and Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Glioma Diagnosis and Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Glioma Diagnosis and Treatment Market Size by Country
10.4.1 Middle East & Africa Glioma Diagnosis and Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Glioma Diagnosis and Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Glioma Diagnosis and Treatment Introduction
11.1.4 Thermo Fisher Scientific Revenue in Glioma Diagnosis and Treatment Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Emcure Pharmaceuticals
11.2.1 Emcure Pharmaceuticals Company Details
11.2.2 Emcure Pharmaceuticals Business Overview
11.2.3 Emcure Pharmaceuticals Glioma Diagnosis and Treatment Introduction
11.2.4 Emcure Pharmaceuticals Revenue in Glioma Diagnosis and Treatment Business (2016-2021)
11.2.5 Emcure Pharmaceuticals Recent Development
11.3 Sigma-Aldrich
11.3.1 Sigma-Aldrich Company Details
11.3.2 Sigma-Aldrich Business Overview
11.3.3 Sigma-Aldrich Glioma Diagnosis and Treatment Introduction
11.3.4 Sigma-Aldrich Revenue in Glioma Diagnosis and Treatment Business (2016-2021)
11.3.5 Sigma-Aldrich Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Glioma Diagnosis and Treatment Introduction
11.4.4 Pfizer Revenue in Glioma Diagnosis and Treatment Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Taj Pharmaceuticals
11.5.1 Taj Pharmaceuticals Company Details
11.5.2 Taj Pharmaceuticals Business Overview
11.5.3 Taj Pharmaceuticals Glioma Diagnosis and Treatment Introduction
11.5.4 Taj Pharmaceuticals Revenue in Glioma Diagnosis and Treatment Business (2016-2021)
11.5.5 Taj Pharmaceuticals Recent Development
11.6 Novartis International
11.6.1 Novartis International Company Details
11.6.2 Novartis International Business Overview
11.6.3 Novartis International Glioma Diagnosis and Treatment Introduction
11.6.4 Novartis International Revenue in Glioma Diagnosis and Treatment Business (2016-2021)
11.6.5 Novartis International Recent Development
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Details
11.7.2 Teva Pharmaceutical Business Overview
11.7.3 Teva Pharmaceutical Glioma Diagnosis and Treatment Introduction
11.7.4 Teva Pharmaceutical Revenue in Glioma Diagnosis and Treatment Business (2016-2021)
11.7.5 Teva Pharmaceutical Recent Development
11.8 GE Healthcare
11.8.1 GE Healthcare Company Details
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Glioma Diagnosis and Treatment Introduction
11.8.4 GE Healthcare Revenue in Glioma Diagnosis and Treatment Business (2016-2021)
11.8.5 GE Healthcare Recent Development
11.9 Siemens Healthcare
11.9.1 Siemens Healthcare Company Details
11.9.2 Siemens Healthcare Business Overview
11.9.3 Siemens Healthcare Glioma Diagnosis and Treatment Introduction
11.9.4 Siemens Healthcare Revenue in Glioma Diagnosis and Treatment Business (2016-2021)
11.9.5 Siemens Healthcare Recent Development
11.10 Philips Healthcare
11.10.1 Philips Healthcare Company Details
11.10.2 Philips Healthcare Business Overview
11.10.3 Philips Healthcare Glioma Diagnosis and Treatment Introduction
11.10.4 Philips Healthcare Revenue in Glioma Diagnosis and Treatment Business (2016-2021)
11.10.5 Philips Healthcare Recent Development
11.11 Shimadzu Corporation
11.11.1 Shimadzu Corporation Company Details
11.11.2 Shimadzu Corporation Business Overview
11.11.3 Shimadzu Corporation Glioma Diagnosis and Treatment Introduction
11.11.4 Shimadzu Corporation Revenue in Glioma Diagnosis and Treatment Business (2016-2021)
11.11.5 Shimadzu Corporation Recent Development
11.12 Canon Medical Systems
11.12.1 Canon Medical Systems Company Details
11.12.2 Canon Medical Systems Business Overview
11.12.3 Canon Medical Systems Glioma Diagnosis and Treatment Introduction
11.12.4 Canon Medical Systems Revenue in Glioma Diagnosis and Treatment Business (2016-2021)
11.12.5 Canon Medical Systems Recent Development
11.13 Merck
11.13.1 Merck Company Details
11.13.2 Merck Business Overview
11.13.3 Merck Glioma Diagnosis and Treatment Introduction
11.13.4 Merck Revenue in Glioma Diagnosis and Treatment Business (2016-2021)
11.13.5 Merck Recent Development
11.14 Roche
11.14.1 Roche Company Details
11.14.2 Roche Business Overview
11.14.3 Roche Glioma Diagnosis and Treatment Introduction
11.14.4 Roche Revenue in Glioma Diagnosis and Treatment Business (2016-2021)
11.14.5 Roche Recent Development
11.15 Arbor Pharmaceuticals
11.15.1 Arbor Pharmaceuticals Company Details
11.15.2 Arbor Pharmaceuticals Business Overview
11.15.3 Arbor Pharmaceuticals Glioma Diagnosis and Treatment Introduction
11.15.4 Arbor Pharmaceuticals Revenue in Glioma Diagnosis and Treatment Business (2016-2021)
11.15.5 Arbor Pharmaceuticals Recent Development
11.16 Sun Pharmaceutical
11.16.1 Sun Pharmaceutical Company Details
11.16.2 Sun Pharmaceutical Business Overview
11.16.3 Sun Pharmaceutical Glioma Diagnosis and Treatment Introduction
11.16.4 Sun Pharmaceutical Revenue in Glioma Diagnosis and Treatment Business (2016-2021)
11.16.5 Sun Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Glioma Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Diagnosis (CT, MRI)
Table 3. Key Players of Treatment (Surgery, Chemotherapy)
Table 4. Global Glioma Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Glioma Diagnosis and Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Glioma Diagnosis and Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Glioma Diagnosis and Treatment Market Share by Regions (2016-2021)
Table 8. Global Glioma Diagnosis and Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Glioma Diagnosis and Treatment Market Share by Regions (2022-2027)
Table 10. Glioma Diagnosis and Treatment Market Trends
Table 11. Glioma Diagnosis and Treatment Market Drivers
Table 12. Glioma Diagnosis and Treatment Market Challenges
Table 13. Glioma Diagnosis and Treatment Market Restraints
Table 14. Global Glioma Diagnosis and Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Glioma Diagnosis and Treatment Market Share by Players (2016-2021)
Table 16. Global Top Glioma Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glioma Diagnosis and Treatment as of 2020)
Table 17. Ranking of Global Top Glioma Diagnosis and Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Glioma Diagnosis and Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Glioma Diagnosis and Treatment Product Solution and Service
Table 21. Date of Enter into Glioma Diagnosis and Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Glioma Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Glioma Diagnosis and Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Glioma Diagnosis and Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Glioma Diagnosis and Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Glioma Diagnosis and Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Glioma Diagnosis and Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Glioma Diagnosis and Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Glioma Diagnosis and Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Glioma Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Glioma Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Glioma Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Glioma Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Glioma Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Glioma Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Glioma Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Glioma Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Glioma Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Glioma Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Glioma Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Glioma Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Glioma Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Glioma Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Glioma Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Glioma Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Glioma Diagnosis and Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Glioma Diagnosis and Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Glioma Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Glioma Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Glioma Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Glioma Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Glioma Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Glioma Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Glioma Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Glioma Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Glioma Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Glioma Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Glioma Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Glioma Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Thermo Fisher Scientific Company Details
Table 62. Thermo Fisher Scientific Business Overview
Table 63. Thermo Fisher Scientific Glioma Diagnosis and Treatment Product
Table 64. Thermo Fisher Scientific Revenue in Glioma Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 65. Thermo Fisher Scientific Recent Development
Table 66. Emcure Pharmaceuticals Company Details
Table 67. Emcure Pharmaceuticals Business Overview
Table 68. Emcure Pharmaceuticals Glioma Diagnosis and Treatment Product
Table 69. Emcure Pharmaceuticals Revenue in Glioma Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 70. Emcure Pharmaceuticals Recent Development
Table 71. Sigma-Aldrich Company Details
Table 72. Sigma-Aldrich Business Overview
Table 73. Sigma-Aldrich Glioma Diagnosis and Treatment Product
Table 74. Sigma-Aldrich Revenue in Glioma Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 75. Sigma-Aldrich Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Glioma Diagnosis and Treatment Product
Table 79. Pfizer Revenue in Glioma Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Taj Pharmaceuticals Company Details
Table 82. Taj Pharmaceuticals Business Overview
Table 83. Taj Pharmaceuticals Glioma Diagnosis and Treatment Product
Table 84. Taj Pharmaceuticals Revenue in Glioma Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 85. Taj Pharmaceuticals Recent Development
Table 86. Novartis International Company Details
Table 87. Novartis International Business Overview
Table 88. Novartis International Glioma Diagnosis and Treatment Product
Table 89. Novartis International Revenue in Glioma Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 90. Novartis International Recent Development
Table 91. Teva Pharmaceutical Company Details
Table 92. Teva Pharmaceutical Business Overview
Table 93. Teva Pharmaceutical Glioma Diagnosis and Treatment Product
Table 94. Teva Pharmaceutical Revenue in Glioma Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 95. Teva Pharmaceutical Recent Development
Table 96. GE Healthcare Company Details
Table 97. GE Healthcare Business Overview
Table 98. GE Healthcare Revenue in Glioma Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 99. GE Healthcare Recent Development
Table 100. Siemens Healthcare Company Details
Table 101. Siemens Healthcare Business Overview
Table 102. Siemens Healthcare Glioma Diagnosis and Treatment Product
Table 103. Siemens Healthcare Revenue in Glioma Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 104. Siemens Healthcare Recent Development
Table 105. Philips Healthcare Company Details
Table 106. Philips Healthcare Business Overview
Table 107. Philips Healthcare Glioma Diagnosis and Treatment Product
Table 108. Philips Healthcare Revenue in Glioma Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 109. Philips Healthcare Recent Development
Table 110. Shimadzu Corporation Company Details
Table 111. Shimadzu Corporation Business Overview
Table 112. Shimadzu Corporation Glioma Diagnosis and Treatment Product
Table 113. Shimadzu Corporation Revenue in Glioma Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 114. Shimadzu Corporation Recent Development
Table 115. Canon Medical Systems Company Details
Table 116. Canon Medical Systems Business Overview
Table 117. Canon Medical Systems Glioma Diagnosis and Treatment Product
Table 118. Canon Medical Systems Revenue in Glioma Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 119. Canon Medical Systems Recent Development
Table 120. Merck Company Details
Table 121. Merck Business Overview
Table 122. Merck Glioma Diagnosis and Treatment Product
Table 123. Merck Revenue in Glioma Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 124. Merck Recent Development
Table 125. Roche Company Details
Table 126. Roche Business Overview
Table 127. Roche Glioma Diagnosis and Treatment Product
Table 128. Roche Revenue in Glioma Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 129. Roche Recent Development
Table 130. Arbor Pharmaceuticals Company Details
Table 131. Arbor Pharmaceuticals Business Overview
Table 132. Arbor Pharmaceuticals Glioma Diagnosis and Treatment Product
Table 133. Arbor Pharmaceuticals Revenue in Glioma Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 134. Arbor Pharmaceuticals Recent Development
Table 135. Sun Pharmaceutical Company Details
Table 136. Sun Pharmaceutical Business Overview
Table 137. Sun Pharmaceutical Glioma Diagnosis and Treatment Product
Table 138. Sun Pharmaceutical Revenue in Glioma Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 139. Sun Pharmaceutical Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Glioma Diagnosis and Treatment Market Share by Type: 2020 VS 2027
Figure 2. Diagnosis (CT, MRI) Features
Figure 3. Treatment (Surgery, Chemotherapy) Features
Figure 4. Global Glioma Diagnosis and Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Glioma Diagnosis and Treatment Report Years Considered
Figure 8. Global Glioma Diagnosis and Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Glioma Diagnosis and Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Glioma Diagnosis and Treatment Market Share by Regions: 2020 VS 2027
Figure 11. Global Glioma Diagnosis and Treatment Market Share by Regions (2022-2027)
Figure 12. Global Glioma Diagnosis and Treatment Market Share by Players in 2020
Figure 13. Global Top Glioma Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glioma Diagnosis and Treatment as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Glioma Diagnosis and Treatment Revenue in 2020
Figure 15. Global Glioma Diagnosis and Treatment Revenue Market Share by Type (2016-2021)
Figure 16. Global Glioma Diagnosis and Treatment Revenue Market Share by Type (2022-2027)
Figure 17. North America Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Glioma Diagnosis and Treatment Market Share by Type (2016-2027)
Figure 19. North America Glioma Diagnosis and Treatment Market Share by Application (2016-2027)
Figure 20. North America Glioma Diagnosis and Treatment Market Share by Country (2016-2027)
Figure 21. United States Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Glioma Diagnosis and Treatment Market Share by Type (2016-2027)
Figure 25. Europe Glioma Diagnosis and Treatment Market Share by Application (2016-2027)
Figure 26. Europe Glioma Diagnosis and Treatment Market Share by Country (2016-2027)
Figure 27. Germany Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Glioma Diagnosis and Treatment Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Glioma Diagnosis and Treatment Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Glioma Diagnosis and Treatment Market Share by Region (2016-2027)
Figure 37. China Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Glioma Diagnosis and Treatment Market Share by Type (2016-2027)
Figure 45. Latin America Glioma Diagnosis and Treatment Market Share by Application (2016-2027)
Figure 46. Latin America Glioma Diagnosis and Treatment Market Share by Country (2016-2027)
Figure 47. Mexico Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Glioma Diagnosis and Treatment Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Glioma Diagnosis and Treatment Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Glioma Diagnosis and Treatment Market Share by Country (2016-2027)
Figure 53. Turkey Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Glioma Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Glioma Diagnosis and Treatment Business (2016-2021)
Figure 57. Emcure Pharmaceuticals Revenue Growth Rate in Glioma Diagnosis and Treatment Business (2016-2021)
Figure 58. Sigma-Aldrich Revenue Growth Rate in Glioma Diagnosis and Treatment Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Glioma Diagnosis and Treatment Business (2016-2021)
Figure 60. Taj Pharmaceuticals Revenue Growth Rate in Glioma Diagnosis and Treatment Business (2016-2021)
Figure 61. Novartis International Revenue Growth Rate in Glioma Diagnosis and Treatment Business (2016-2021)
Figure 62. Teva Pharmaceutical Revenue Growth Rate in Glioma Diagnosis and Treatment Business (2016-2021)
Figure 63. GE Healthcare Revenue Growth Rate in Glioma Diagnosis and Treatment Business (2016-2021)
Figure 64. Siemens Healthcare Revenue Growth Rate in Glioma Diagnosis and Treatment Business (2016-2021)
Figure 65. Philips Healthcare Revenue Growth Rate in Glioma Diagnosis and Treatment Business (2016-2021)
Figure 66. Shimadzu Corporation Revenue Growth Rate in Glioma Diagnosis and Treatment Business (2016-2021)
Figure 67. Canon Medical Systems Revenue Growth Rate in Glioma Diagnosis and Treatment Business (2016-2021)
Figure 68. Merck Revenue Growth Rate in Glioma Diagnosis and Treatment Business (2016-2021)
Figure 69. Roche Revenue Growth Rate in Glioma Diagnosis and Treatment Business (2016-2021)
Figure 70. Arbor Pharmaceuticals Revenue Growth Rate in Glioma Diagnosis and Treatment Business (2016-2021)
Figure 71. Sun Pharmaceutical Revenue Growth Rate in Glioma Diagnosis and Treatment Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の視神経膠腫市場規模・現状・予測（2021年-2027年） An optic nerve glioma is a type of brain tumor. There are multiple kinds of brain tumors. Typically, each type of tumor is named after the kinds of cells it affects. Most optic nerve gliomas are considered low-grade and don’t grow as quickly as other types of brain tumors. They are found in the opti…- 世界の視神経膠腫市場規模・現状・予測（2021年-2027年） An optic nerve glioma is a type of brain tumor. There are multiple kinds of brain tumors. Typically, each type of tumor is named after the kinds of cells it affects. Most optic nerve gliomas are considered low-grade and don’t grow as quickly as other types of brain tumors. They are found in the opti…
- 世界のてんかん診断・治療市場規模・現状・予測（2021年-2027年） Epilepsy is a neurological disorder affecting the central nervous system. In this medical condition, the brain exhibits abnormal activity, which results in periods of unusual behavior or seizures and sometimes, loss of awareness. Temporary confusion, anxiety, uncontrollable jerking movements of the …
- 世界の髄膜炎診断・治療市場規模・現状・予測（2021年-2027年） Meningitis is an acute inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges. The most common symptoms are fever, headache, and neck stiffness. Other symptoms include confusion or altered consciousness, vomiting, and an inability to tolerate …
- 世界のHIV診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global HIV Diagnosis and Treatment Market The global HIV Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…